Mariner LLC Acquires Shares of 13,298 Premier, Inc. (NASDAQ:PINC)

Mariner LLC bought a new position in shares of Premier, Inc. (NASDAQ:PINC) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 13,298 shares of the company’s stock, valued at approximately $282,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Brooklyn Investment Group grew its stake in shares of Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock worth $26,000 after acquiring an additional 1,235 shares in the last quarter. SRS Capital Advisors Inc. boosted its holdings in Premier by 157.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock worth $27,000 after purchasing an additional 786 shares during the last quarter. Keystone Financial Group Inc. bought a new stake in Premier in the 4th quarter worth about $37,000. Wilmington Savings Fund Society FSB purchased a new stake in Premier in the 3rd quarter valued at about $39,000. Finally, Smartleaf Asset Management LLC lifted its position in shares of Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock worth $40,000 after buying an additional 1,427 shares in the last quarter. Institutional investors and hedge funds own 74.41% of the company’s stock.

Analysts Set New Price Targets

PINC has been the subject of several recent analyst reports. Canaccord Genuity Group reduced their target price on Premier from $21.00 to $19.00 and set a “hold” rating for the company in a report on Wednesday, February 5th. Robert W. Baird lowered their target price on Premier from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Finally, Piper Sandler cut their price target on shares of Premier from $21.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Eight analysts have rated the stock with a hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.17.

Insider Transactions at Premier

In related news, General Counsel David L. Klatsky sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total transaction of $195,300.00. Following the sale, the general counsel now owns 90,597 shares of the company’s stock, valued at approximately $1,769,359.41. This represents a 9.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.96% of the company’s stock.

Premier Price Performance

NASDAQ:PINC opened at $20.51 on Tuesday. The company has a market cap of $1.87 billion, a P/E ratio of -205.08 and a beta of 0.54. Premier, Inc. has a 1 year low of $17.23 and a 1 year high of $23.56. The stock’s fifty day moving average price is $19.09 and its two-hundred day moving average price is $20.46.

Premier Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Sunday, June 15th. Stockholders of record on Sunday, June 1st will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 4.10%. The ex-dividend date is Friday, May 30th. Premier’s dividend payout ratio is presently -840.00%.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.